Avoiding 483 Observations: Common eBMR Pitfalls in Pharma and How to Fix Them
The Rising FDA Scrutiny of eBMR Systems In recent FDA inspections, over 60% of 483 observations in pharma manufacturing cited electronic batch record (eBMR) failures—from missing audit trails to unchecked overrides. These findings delay approvals and cost millions in remediation. This blog reveals: Top 5 eBMR-related 483 observations (based on FDA public data) Proven fixes […]










